Cargando…
MCAM is associated with metastasis and poor prognosis in osteosarcoma by modulating tumor cell migration
BACKGROUND: Although there are standard treatment options for osteosarcoma (OS), the prognoses of patients with OS remain varied. Therefore, it is important to profile OS patients at a high risk of mortality to develop focused interventions. Although tumor biomarkers are closely associated with clin...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841137/ https://www.ncbi.nlm.nih.gov/pubmed/34961985 http://dx.doi.org/10.1002/jcla.24214 |